What Is Linagliptin Used For?
If you have type 2 diabetes, a healthcare provider may prescribe linagliptin. This medication works by increasing insulin levels after meals and decreasing the amount of glucose (sugar) produced by the liver. This diabetes drug is only approved for use in adults.
An Introduction to Uses for LinagliptinLinagliptin (Tradjenta™) is a prescription medication used to treat type 2 diabetes. This medicine should be used in combination with appropriate changes in diet and exercise to help control blood sugar levels. It can be used alone or in combination with other diabetes medications, including insulin.
Type 2 diabetes is the most common type of diabetes (see Diabetes Types). It is also sometimes called adult-onset diabetes or noninsulin-dependent diabetes. Type 2 diabetes is a condition in which the cells in the body do not respond to insulin as well as they normally should. As a result, the cells do not adequately remove sugar from the blood. This is why people with type 2 diabetes have high blood sugar levels.
Over time, high blood sugar levels can lead to a number of problems, including diabetic impotence, diabetic neuropathy, kidney failure, and heart disease (see Diabetes Complications). The cause of type 2 diabetes is not fully understood, although it is known that obesity and genetics play an important role in the development of the disease.
Any type 2 diabetes treatment begins with lifestyle changes, such as weight loss, a diabetic diet, and exercise. If lifestyle changes are not effective at managing diabetes, diabetes medication, such as linagliptin, may be necessary.
Some diabetes drugs force the pancreas to produce more insulin regardless of blood sugar levels. These medications are effective, but can cause dangerously low blood sugar levels (hypoglycemia). Because of the way linagliptin works, it is far less likely to cause dangerously low blood sugar levels, compared with some other diabetes medications.
(To learn about controlling diabetes through lifestyle changes, click on any of the links below: